UniProt ID | CDC6_HUMAN | |
---|---|---|
UniProt AC | Q99741 | |
Protein Name | Cell division control protein 6 homolog | |
Gene Name | CDC6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 560 | |
Subcellular Localization | Nucleus . Cytoplasm . The protein is nuclear in G1 and cytoplasmic in S-phase cells (PubMed:9566895). | |
Protein Description | Involved in the initiation of DNA replication. Also participates in checkpoint controls that ensure DNA replication is completed before mitosis is initiated.. | |
Protein Sequence | MPQTRSQAQATISFPKRKLSRALNKAKNSSDAKLEPTNVQTVTCSPRVKALPLSPRKRLGDDNLCNTPHLPPCSPPKQGKKENGPPHSHTLKGRRLVFDNQLTIKSPSKRELAKVHQNKILSSVRKSQEITTNSEQRCPLKKESACVRLFKQEGTCYQQAKLVLNTAVPDRLPAREREMDVIRNFLREHICGKKAGSLYLSGAPGTGKTACLSRILQDLKKELKGFKTIMLNCMSLRTAQAVFPAIAQEICQEEVSRPAGKDMMRKLEKHMTAEKGPMIVLVLDEMDQLDSKGQDVLYTLFEWPWLSNSHLVLIGIANTLDLTDRILPRLQAREKCKPQLLNFPPYTRNQIVTILQDRLNQVSRDQVLDNAAVQFCARKVSAVSGDVRKALDVCRRAIEIVESDVKSQTILKPLSECKSPSEPLIPKRVGLIHISQVISEVDGNRMTLSQEGAQDSFPLQQKILVCSLMLLIRQLKIKEVTLGKLYEAYSKVCRKQQVAAVDQSECLSLSGLLEARGILGLKRNKETRLTKVFFKIEEKEIEHALKDKALIGNILATGLP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Phosphorylation | SFPKRKLSRALNKAK HCCHHHHHHHHHHHC | 20.67 | 21406692 | |
25 | Ubiquitination | KLSRALNKAKNSSDA HHHHHHHHHCCCCCC | 62.68 | 21906983 | |
27 | Ubiquitination | SRALNKAKNSSDAKL HHHHHHHCCCCCCCC | 60.00 | 21906983 | |
33 | Ubiquitination | AKNSSDAKLEPTNVQ HCCCCCCCCCCCCCE | 59.37 | - | |
37 | Phosphorylation | SDAKLEPTNVQTVTC CCCCCCCCCCEEEEC | 38.35 | 23927012 | |
41 | Phosphorylation | LEPTNVQTVTCSPRV CCCCCCEEEECCCCC | 17.31 | 29255136 | |
43 | Phosphorylation | PTNVQTVTCSPRVKA CCCCEEEECCCCCEE | 15.62 | 23401153 | |
45 | Phosphorylation | NVQTVTCSPRVKALP CCEEEECCCCCEECC | 13.33 | 29255136 | |
49 | Ubiquitination | VTCSPRVKALPLSPR EECCCCCEECCCCCC | 45.55 | - | |
54 | Phosphorylation | RVKALPLSPRKRLGD CCEECCCCCCCCCCC | 22.25 | 9889196 | |
67 | Phosphorylation | GDDNLCNTPHLPPCS CCCCCCCCCCCCCCC | 15.87 | 25159151 | |
74 | Phosphorylation | TPHLPPCSPPKQGKK CCCCCCCCCCCCCCC | 50.43 | 9889196 | |
88 | Phosphorylation | KENGPPHSHTLKGRR CCCCCCCCCCCCCCE | 24.76 | 25159151 | |
90 | Phosphorylation | NGPPHSHTLKGRRLV CCCCCCCCCCCCEEE | 32.93 | 20860994 | |
92 | Acetylation | PPHSHTLKGRRLVFD CCCCCCCCCCEEEEC | 52.07 | 19343071 | |
92 | Ubiquitination | PPHSHTLKGRRLVFD CCCCCCCCCCEEEEC | 52.07 | - | |
103 | Phosphorylation | LVFDNQLTIKSPSKR EEECCCEEECCCCHH | 19.32 | 24732914 | |
105 | Acetylation | FDNQLTIKSPSKREL ECCCEEECCCCHHHH | 51.59 | 19343071 | |
106 | Phosphorylation | DNQLTIKSPSKRELA CCCEEECCCCHHHHH | 30.47 | 9889196 | |
108 | Phosphorylation | QLTIKSPSKRELAKV CEEECCCCHHHHHHH | 51.97 | 24732914 | |
109 | Acetylation | LTIKSPSKRELAKVH EEECCCCHHHHHHHH | 53.96 | 19343071 | |
114 | Ubiquitination | PSKRELAKVHQNKIL CCHHHHHHHHHHHHH | 53.53 | - | |
119 | Ubiquitination | LAKVHQNKILSSVRK HHHHHHHHHHHHHHH | 38.15 | - | |
122 | Phosphorylation | VHQNKILSSVRKSQE HHHHHHHHHHHHHHC | 30.20 | 24732914 | |
123 | Phosphorylation | HQNKILSSVRKSQEI HHHHHHHHHHHHHCC | 23.61 | 24732914 | |
126 | Ubiquitination | KILSSVRKSQEITTN HHHHHHHHHHCCCCC | 55.10 | - | |
127 | Phosphorylation | ILSSVRKSQEITTNS HHHHHHHHHCCCCCC | 23.60 | 25159151 | |
131 | Phosphorylation | VRKSQEITTNSEQRC HHHHHCCCCCCCCCC | 21.12 | 24732914 | |
132 | Phosphorylation | RKSQEITTNSEQRCP HHHHCCCCCCCCCCC | 42.27 | 24732914 | |
134 | Phosphorylation | SQEITTNSEQRCPLK HHCCCCCCCCCCCCC | 32.77 | 21815630 | |
151 | Acetylation | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | 26051181 | |
151 | Sumoylation | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | - | |
151 | Sumoylation | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | - | |
151 | Ubiquitination | SACVRLFKQEGTCYQ HHHHHHHHCCCCHHH | 52.62 | - | |
166 | Phosphorylation | QAKLVLNTAVPDRLP HHHHHHCCCCCCCCC | 25.52 | 29632367 | |
194 | Ubiquitination | REHICGKKAGSLYLS HHHHCCCCCCCEEEC | 43.17 | - | |
199 | Phosphorylation | GKKAGSLYLSGAPGT CCCCCCEEECCCCCC | 10.66 | 29496907 | |
208 | Ubiquitination | SGAPGTGKTACLSRI CCCCCCCHHHHHHHH | 32.55 | - | |
220 | Ubiquitination | SRILQDLKKELKGFK HHHHHHHHHHHCCCC | 53.11 | - | |
221 | Ubiquitination | RILQDLKKELKGFKT HHHHHHHHHHCCCCH | 75.48 | - | |
235 | Phosphorylation | TIMLNCMSLRTAQAV HHHHHHCCHHHHHHH | 19.52 | 29083192 | |
261 | Ubiquitination | EVSRPAGKDMMRKLE HCCCHHHHHHHHHHH | 44.55 | - | |
379 | Ubiquitination | AVQFCARKVSAVSGD HHHHHHHHHHHCCCH | 23.24 | - | |
381 | Phosphorylation | QFCARKVSAVSGDVR HHHHHHHHHCCCHHH | 26.45 | 20068231 | |
384 | Phosphorylation | ARKVSAVSGDVRKAL HHHHHHCCCHHHHHH | 29.06 | 20068231 | |
389 | Ubiquitination | AVSGDVRKALDVCRR HCCCHHHHHHHHHHH | 53.82 | - | |
406 | Ubiquitination | EIVESDVKSQTILKP HHHHCCCCCCCCCCC | 41.66 | - | |
407 | Phosphorylation | IVESDVKSQTILKPL HHHCCCCCCCCCCCH | 32.19 | 24732914 | |
409 | Phosphorylation | ESDVKSQTILKPLSE HCCCCCCCCCCCHHH | 35.05 | 29214152 | |
412 | Ubiquitination | VKSQTILKPLSECKS CCCCCCCCCHHHCCC | 39.81 | - | |
415 | Phosphorylation | QTILKPLSECKSPSE CCCCCCHHHCCCCCC | 49.85 | 24732914 | |
418 | Ubiquitination | LKPLSECKSPSEPLI CCCHHHCCCCCCCCC | 62.44 | - | |
419 | Phosphorylation | KPLSECKSPSEPLIP CCHHHCCCCCCCCCC | 45.37 | 25159151 | |
421 | Phosphorylation | LSECKSPSEPLIPKR HHHCCCCCCCCCCCC | 59.96 | 21815630 | |
427 | Ubiquitination | PSEPLIPKRVGLIHI CCCCCCCCCEEEEEH | 53.36 | - | |
478 | Ubiquitination | LIRQLKIKEVTLGKL HHHHHCCCCCHHHHH | 44.54 | - | |
481 | Phosphorylation | QLKIKEVTLGKLYEA HHCCCCCHHHHHHHH | 30.77 | - | |
484 | Ubiquitination | IKEVTLGKLYEAYSK CCCCHHHHHHHHHHH | 51.51 | - | |
491 | Ubiquitination | KLYEAYSKVCRKQQV HHHHHHHHHHHHHHC | 32.45 | - | |
495 | Ubiquitination | AYSKVCRKQQVAAVD HHHHHHHHHHCEEEC | 39.70 | - | |
527 | Phosphorylation | GLKRNKETRLTKVFF CCCCCCCCCCEEEEE | 32.37 | 22210691 | |
531 | Ubiquitination | NKETRLTKVFFKIEE CCCCCCEEEEEEECH | 41.45 | - | |
535 | Ubiquitination | RLTKVFFKIEEKEIE CCEEEEEEECHHHHH | 37.43 | - | |
539 | Ubiquitination | VFFKIEEKEIEHALK EEEEECHHHHHHHHH | 51.72 | - | |
546 | Ubiquitination | KEIEHALKDKALIGN HHHHHHHHCHHHHHH | 58.95 | - | |
548 | Ubiquitination | IEHALKDKALIGNIL HHHHHHCHHHHHHHH | 43.43 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
37 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
54 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
74 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
106 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:10995389 |
- | K | Ubiquitination | E3 ubiquitin ligase | CCNF | P41002 | PMID:26818844 |
- | K | Ubiquitination | E3 ubiquitin ligase | HUWE1 | Q7Z6Z7 | PMID:18617514 |
- | K | Ubiquitination | E3 ubiquitin ligase | TOM1 | O60784 | PMID:23129771 |
- | K | Ubiquitination | E3 ubiquitin ligase | DTL | Q9NZJ0 | PMID:24434580 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CDC6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDC6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
613805 | Meier-Gorlin syndrome 5 (MGORS5) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45 AND SER-54, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-166, AND MASSSPECTROMETRY. |